Ceribell (CBLL) Capital Expenditures Growth (1y) (2024 - 2025)

Ceribell (CBLL) Capital Expenditures Growth (1y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -17.56%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 34.96%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 6.32%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 15.89%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -11.95%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -47.73%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 106.98%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Ceribell 613.16 Mn 471.97 Mn 23.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 81.15%
Sep 30, 2025 -58.91%
Jun 30, 2025 52.70%
Dec 31, 2024 -292.45%